INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1979

High-dose vitamin C therapy did not improve symptoms, performance status, weight, or survival in patients with advanced cancer.

A controlled double-blind study evaluated the effects of high-dose vitamin C (10 g per day) compared to a flavored lactose placebo in 150 patients with advanced cancer. Among evaluable patients (60 receiving vitamin C and 63 placebo), no appreciable differences were found in changes in symptoms, performance status, appetite, or weight. The median survival for all patients was about seven weeks, with essentially overlapping survival curves, showing no therapeutic benefit from vitamin C in this cohort.

Study type
Double-blind randomized controlled trial
Who was studied
150 patients with advanced cancer (60 evaluable on vitamin C, 63 on placebo)
What was measured
Symptoms, performance status, appetite, weight, and survival

THE PAPER

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. N Engl J Med, 1979.

PubMed 384241 ↗DOI 10.1056/nejm197909273011303 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.